Haemonetics (HAE) Non-Current Debt (2010 - 2026)

Haemonetics' Non-Current Debt history runs 17 years deep, the most recent figure standing at $1.2 billion for Q1 2026.

• On a quarterly basis, Non-Current Debt rose 32.38% year-over-year to $1.2 billion in Q1 2026; TTM through Mar 2026 was $1.2 billion, a 32.38% increase from a year earlier, with the FY2026 full-year figure at $1.2 billion, up 32.38% from the prior year.
• Non-Current Debt steadied at $1.2 billion in Q1 2026 per HAE's latest filing, from $1.2 billion in the prior quarter.
• Across five years, Non-Current Debt topped out at $1.2 billion in Q4 2025 and bottomed at $559.4 million in Q2 2022.
• The 5-year median for Non-Current Debt is $827.2 million (2023), against an average of $902.5 million.
• Across the five-year window, Non-Current Debt jumped 116.29% in 2022 and retreated 24.53% in 2025, its largest moves.
• Year by year, Non-Current Debt stood at $756.8 million in 2022, then increased by 13.22% to $856.8 million in 2023, then jumped by 42.35% to $1.2 billion in 2024, then gained by 0.41% to $1.2 billion in 2025, then slipped by 0.42% to $1.2 billion in 2026.
• Per Business Quant, the three latest HAE Non-Current Debt figures stand at $1.2 billion (Q1 2026), $1.2 billion (Q4 2025), and $920.4 million (Q3 2025).